CROS NT has expanded its life sciences technology portfolio by joining the DATATRAK Connect™ Program – a program which allows for extended service offerings for the drug development process with the goal of reducing study costs and furthering business development objectives.
Under this partnership program, CROS NT can provide DATATRAK’s clinical trial technologies including Electronic Data Capture & reporting (EDC), Clinical Trial Management System (CTMS), randomization and clinical trial supply management (IRT), and web based patient diary (ePRO).
Paul Fardy, Chief Operations Officer, said “the DATATRAK partnership is an ideal solution for a biometrics CRO like CROS NT since they offer a range of clinical trial technologies that are delivered as an integrated solution. The majority of our customers are seeking this type of solution – a comprehensive offering of technology to enhance the quality of clinical data in an efficient and convenient manner.”
“We are pleased to welcome CROS NT into the DATATRAK Connect™ Partner Program,” stated Laurence P. Birch, DATATRAK’s Chairman of the Board and CEO. “Our DATATRAK ONE™ technology will enhance their centre of excellence for clinical trial data.”
As part of CROS NT’s service offering of data management, statistics, pharmacovigilance and medical writing, the company also provides integrated ePRO and EDC solutions.